Nuclear Sector Overview — October 2026
Summary
Nuclear's fundamentals are improving, not declining. What has fallen is the speculative end of the sector, small modular reactor start-ups, after an AI-driven bubble in 2025.
- What's falling: pre-revenue reactor developers. Oklo was down about 39% for 2026 in September and about 75% below its peak; NuScale was down about 24%.
- Why: commercial reactors are years away, valuations ran far ahead of earnings, heavy share issuance and insider selling, the AI-trade rotation, and analysts starting to pick winners.
- What's holding up: profitable operators such as Constellation (2026 guidance raised) and the uranium market (long-term contract price at a record $96/lb).
- Bottom line: the earnings-backed part of the sector (operators, fuel) has a strong demand story but is not cheap; the SMR names are high-risk, long-dated bets.
Why nuclear stocks are declining in 2026
The decline is mostly a correction in speculative, pre-revenue reactor developers after a 2025 bubble, not a deterioration in the industry. The VanEck Uranium and Nuclear ETF (NLR) rose over 50% in 2025 but was down about 15% by mid-July 2026 (Stocktwits). Oklo was about 39% down for the year in early September and roughly 75% below its October 2025 high of $193; NuScale was down about 24% (24/7 Wall St). Profitable operators held up: Constellation fell 2% and Vistra rose 5% during Oklo's 28% July slide (24/7 Wall St).
- A reckoning with timelines. Small modular reactor (SMR) developers have no revenue. Oklo targets first commercial power in late 2027 to early 2028; NuScale expects first module delivery no earlier than 2031, and TD Cowen warned its Romania project could slip to 2034.
- Valuations ran far ahead of fundamentals. NuScale was worth about $3.6bn against roughly $1.1bn of net assets in June, with negative earnings (Motley Fool).
- Supply of stock: dilution, IPOs and insider exits. Oklo raised money through new share offerings; Fluor sold its entire NuScale stake for about $2.4bn by April; X-Energy's $1bn April IPO gave investors a new, competing way to own the theme.
- Company-specific blows. NuScale disclosed a $507m milestone payment to its commercial partner ENTRA1 with no guaranteed revenue attached.
- AI-trade rotation. Nuclear was sold as an "AI power" play, so rotations out of AI stocks hit it directly, with several 5-9% single-day drops in 2026.
- Analysts now separating winners from losers. Piper Sandler's split ratings on 10 September knocked the whole SMR group down about 5% in a day.
- Lumpy results at quality names. Cameco's Q2 adjusted EBITDA fell 42% because a one-off 2025 Westinghouse contract (Dukovany) did not repeat; the stock still rose 7% on the day.
Market overview and fundamentals
The underlying industry is the strongest it has been in decades: record output, record uranium contract prices and rising forecasts.
| Indicator | Latest | Source |
|---|---|---|
| Global nuclear generation | Record 2,702 TWh in 2025, about 9% of world electricity; capacity factor 83.7% | World Nuclear Association |
| Operating fleet | 413 reactors at end-2025 | IAEA via oEnergetice |
| Under construction | 82 GWe (up from 76 GWe); about half in China | World Nuclear Association |
| New construction starts 2025 | 11 reactors (9 China, 2 Russia) | World Nuclear Association |
| 2050 outlook | 1,457 GWe if national targets are met, roughly triple today | World Nuclear Association |
| IAEA outlook (Sep 2026) | Raised; capacity could triple by 2060, SMRs 28% of new build in high case | IAEA |
| Uranium long-term contract price | Record $96/lb, above the 2007 high; spot about $90/lb (Sep 2026) | Crux Investor |
Policy is supportive. The US targets 400 GW of nuclear by 2050 (from about 100 GW). Four DOE-authorised advanced reactors reached criticality by 4 July 2026, beating the goal of three, though none yet supplies power to a grid (DOE; Environment+Energy Leader). FERC's December 2025 order told PJM to write clear rules for data centres co-located at power plants.
Demand is real and contracted. Constellation signed about 920 MW of new long-term nuclear PPAs in Q2 2026 alone, including Walmart's first nuclear deal. Hyperscalers are signing nuclear restarts (Crane/Three Mile Island for Microsoft; Duane Arnold for Google).
The structural challenge: tripling capacity by 2050 needs build rates about six times today's, and around 46% of operating reactors are over 40 years old.
Value chain and competitive landscape
Money is made today by those who own running reactors or sell fuel; reactor developers are option bets on the 2030s.
| Segment | Company (ticker) | Latest results / status | Risk profile |
|---|---|---|---|
| Operators | Constellation (CEG) | Q2 adj. EPS $2.55 (from $1.91); 2026 guide raised to $11.50-12.50; Calpine acquired for $21.8bn | Earnings now; data-centre deal timing |
| Operators | Vistra (VST) | 2026 adj. EBITDA guide $6.8-7.6bn reaffirmed; upgraded to investment grade by Fitch | Earnings now; power-price exposure |
| Fuel / services | Cameco (CCJ) | H1 adj. EBITDA C$899m; Q2 down on one-off Westinghouse comparison; realised-price guidance raised | Mature; lumpy Westinghouse results; possible Westinghouse IPO |
| Reactor vendor | Westinghouse (49% Cameco) | Technology in 57% of world fleet; 91 AP1000 opportunities (105 GWe) | Large-project execution |
| SMR developers | Oklo (OKLO) | Pre-revenue; first power targeted late 2027-28; not yet NRC-licensed | Very high; dilution |
| SMR developers | NuScale (SMR) | Only NRC-certified SMR design; $1.9bn cash; first module 2031 at earliest | Very high; partner and timeline risk |
| SMR developers | X-Energy (XE) | IPO April 2026, about $1.1bn raised; Amazon, Dow, Centrica as customers | Very high; early public life |
Other listed exposures worth knowing: BWX Technologies (naval and fuel), uranium miners (Kazatomprom, NexGen, Uranium Energy), and the Sprott Physical Uranium Trust for the commodity itself.
Valuation context and investment implications
Whether nuclear is a good investment depends almost entirely on which part you buy: the earnings-backed operators and fuel suppliers rest on strengthening fundamentals, while the SMR developers remain long-dated, binary bets even after their fall.
- Operators (Constellation, Vistra): Constellation traded at about 22x trailing earnings in July against raised guidance; these are priced as growth utilities, so the risk is paying too much rather than the business failing.
- Fuel (Cameco, uranium): record term prices feed through to realised prices with a lag as old contracts roll off; Cameco is down sharply from its February peak despite that.
- SMR developers (Oklo, NuScale, X-Energy): still valued on 2030s outcomes; further dilution is likely because building first plants needs capital.
| Debate | Bull case | Bear case |
|---|---|---|
| Is the AI power demand real? | Hyperscalers are signing 20-year nuclear PPAs and restarts | Data-centre deals have paused at times; regulators may limit co-location |
| Can SMRs be built on time and budget? | DOE pilot reactors reached criticality fast | No SMR supplies a grid in the US; first-of-a-kind projects usually overrun |
| Uranium supply | Term price at record; new mines need $85-90/lb | Spot has been flat since January; Kazakh supply could recover |
| Policy | Bipartisan US support; IAEA and WNA outlooks raised | Licensing, waste and cost overruns remain |
Catalysts to watch: Q3 results (late Oct to mid Nov); Oklo's NRC licensing steps; Crane restart progress; PJM co-location rules; a possible Westinghouse IPO; utilities' year-end uranium contracting.
Sources and caveats
Data as of early October 2026; share-price moves are from articles dated July to September 2026 and will have changed. Not investment advice.
- World Nuclear Association: World Nuclear Outlook 2026
- IAEA outlook (oEnergetice)
- Crux Investor: record uranium term price
- DOE: fourth reactor criticality
- Constellation Q2 2026 (Nasdaq/Zacks)
- Cameco Q2 2026 results
- 24/7 Wall St: Oklo July slide
- 24/7 Wall St: September rebound and YTD
- 24/7 Wall St: Piper Sandler split ratings
- Stocktwits: NLR performance and July sell-off
- Motley Fool: NuScale valuation
Disclaimer: The content provided on this website is for general information and educational purposes only. It is not intended to, and does not, constitute financial advice, investment advice, or a recommendation to engage in any financial activity. RNEquityInsights is not authorised or regulated by the Financial Conduct Authority (FCA) and does not provide regulated investment services or advice.
